SAFETY AND TOLERABILITY OF BAZEDOXIFENE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS OF A 5-YEAR, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

被引:0
|
作者
Kendler, D. L. [1 ]
Chines, A. A. [3 ]
Lips, P. [4 ]
Kaufman, J. M. [5 ]
Levine, A. B. [3 ]
Mairon, N. [6 ]
Codreanu, C. [7 ]
Felsenberg, D. [8 ]
Brown, J. P.
De Villiers, T. J. [2 ,9 ,10 ]
机构
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Univ Laval, Res Ctr, CHUL, Quebec City, PQ, Canada
[3] Pfizer Inc, Collegeville, PA USA
[4] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[5] Ghent Univ Hosp, B-9000 Ghent, Belgium
[6] Wyeth Ayerst Res, Paris, France
[7] Ctr Rheumat Dis, Bucharest, Romania
[8] Charite, Ctr Muscle & Bone Res, D-13353 Berlin, Germany
[9] Panorama MediClin, Cape Town, South Africa
[10] Univ Stellenbosch, Cape Town, South Africa
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:339 / 340
页数:2
相关论文
共 50 条
  • [41] Efficacy of bazedoxifene for the prevention of postmenopausal osteoporosis: Results of a 2-year, phase III, placebo- and active-controlled study
    Kendler, D. L.
    Miller, P. D.
    Christiansen, C.
    Hoeck, H. C.
    Adachi, J. D.
    Lewiecki, E. M.
    Woodson, G.
    Ciesielska, M.
    Chines, A. A.
    Constantine, G.
    Delmas, P. D.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1189 - 1189
  • [42] Efficacy of bazedoxifene for the prevention of postmenopausal osteoporosis: Results of a 2-year, Phase III, placebo- and active-controlled study
    Miller, P. D.
    Christiansen, C.
    Hoeck, H. C.
    Kendler, D. L.
    Lewiecki, E. M.
    Woodson, G.
    Ciesielska, M.
    Chines, A. A.
    Constantine, G.
    Delmas, P. D.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S237 - S238
  • [43] SAFETY AND EFFICACY OF ODANACATIB IN THE TREATMENT OF MEN WITH OSTEOPOROSIS: A RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Chapurlat, R. D.
    Orwoll, E.
    Adami, S.
    Binkley, N.
    Langdahl, B.
    Doleckyj, S.
    Giezek, H.
    Scott, B. B.
    Santora, A. C.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S53 - S54
  • [44] Double-blind, Placebo-controlled, Dose-response Study of Bazedoxifene in Japanese Postmenopausal Women with Osteoporosis.
    Itabashi, A.
    Ohta, H.
    Ebede, B.
    Constantine, G.
    Chines, A. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S472 - S472
  • [45] Effect of alendronate on periodontal disease in postmenopausal women: A randomized placebo-controlled trial
    Rocha, ML
    Malacara, JM
    Sánchez-Marin, FJ
    de la Torre, CJV
    Fajardo, ME
    JOURNAL OF PERIODONTOLOGY, 2004, 75 (12) : 1579 - 1585
  • [47] Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial
    Bachmann, Gloria
    Crosby, Uel
    Feldman, Robert A.
    Ronkin, Sheila
    Constantine, Ginger D.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (05): : 508 - 514
  • [48] Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials
    Simon, James A.
    Altomare, Corrado
    Cort, Susannah
    Jiang, Wei
    Pinkerton, JoAnn V.
    JOURNAL OF WOMENS HEALTH, 2018, 27 (01) : 14 - 23
  • [49] Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-Term Odanacatib Fracture Trial
    McClung, Michael R.
    Langdahl, Bente
    Papapoulos, Socrates
    Saag, Kenneth G.
    Bone, Henry
    Kiel, Douglas P.
    Lippuner, Kurt
    Nakamura, Toshitaka
    Reid, Ian
    Heyden, Norman
    DaSilva, Carolyn
    Scott, Boyd B.
    Massaad, Rachid
    Kaufman, Keith D.
    Stoch, Aubrey
    Santora, Arthur
    Gurner, Deborah
    Lombardi, Antonio
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] A phase I, randomized, placebo-controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults
    Mao, Xiaomeng
    Hua, Xiaohan
    Wu, Chengyi
    Ge, Xiaoyun
    Zhang, Jie
    Wu, Xiaojie
    Kubiak, Robert J.
    Hamren, Ulrika Waehlby
    Villafana, Tonya
    Christou, Georgios
    Green, Jannine
    Takas, Therese
    Jin, Yuwen
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (01):